UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fragile X-Associated Tremor/Ataxia Syndrome: Clinical Phenotype, Diagnosis, and Treatment

Journal of investigative medicine, 2009-12, Vol.57 (8), p.830-836

Leehey, Maureen A.

2009

Volltextzugriff (PDF)

Fragile-X syndrome and fragile X-associated tremor/ataxia syndrome: two faces of FMR1

Lancet neurology, 2007-01, Vol.6 (1), p.45-55

2007

Volltextzugriff (PDF)

Safety and Tolerability of Cannabidiol in Parkinson Disease: An Open Label, Dose-Escalation Study

Cannabis and cannabinoid research, 2020-12, Vol.5 (4), p.326-336

2020

Volltextzugriff (PDF)

A Review of the Current Evidence Connecting Seborrheic Dermatitis and Parkinson's Disease and the Potential Role of Oral Cannabinoids

Dermatology (Basel), 2021-11, Vol.237 (6), p.872-877

2021

Volltextzugriff (PDF)

Fragile X-associated tremor/ataxia syndrome: Clinical features, genetics, and testing guidelines

Movement disorders, 2007-10, Vol.22 (14), p.2018-2030

2007

Volltextzugriff (PDF)

Acute akathisia following initiation of opicapone: A case report

Clinical parkinsonism & related disorders, 2022-01, Vol.7, p.100154-100154, Article 100154

2022

Volltextzugriff (PDF)

Fragile X-associated tremor ataxia syndrome rating scale: Revision and content validity using a mixed method approach

Frontiers in neurology, 2022-09, Vol.13, p.977380-977380

2022

Volltextzugriff (PDF)

Long-term follow-up of a randomized AAV2- GAD gene therapy trial for Parkinson's disease

JCI insight, 2017-04, Vol.2 (7), p.e90133-e90133

2017

Volltextzugriff (PDF)

Clinical Phenotype of Adult Fragile X Gray Zone Allele Carriers: a Case Series

Cerebellum (London, England), 2016-10, Vol.15 (5), p.623-631

2016

Volltextzugriff (PDF)

Reply to: Cognitive Safety of Cannabis Products in Parkinson's Disease: Need for Solid Scientific Evidence to Guide Clinicians and Patients Currently on Shaky Grounds

Movement disorders, 2024-01, Vol.39 (1), p.222-223

2024

Volltextzugriff (PDF)

Oral Cannabidiol for Seborrheic Dermatitis in Patients With Parkinson Disease: Randomized Clinical Trial

JMIR dermatology, 2024-03, Vol.7, p.e49965-e49965

2024

Volltextzugriff (PDF)

Progression of tremor and ataxia in male carriers of the FMR1 premutation

Movement disorders, 2007-01, Vol.22 (2), p.203-206

2007

Volltextzugriff (PDF)

Cognitive Safety Data from a Randomized, Double‐Blind, Parallel‐Group, Placebo‐Controlled Phase IIb Study of the Effects of a Cannabidiol and Δ9‐Tetrahydrocannabinol Drug on Parkinson's Disease‐Related Motor Symptoms

Movement disorders, 2023-07, Vol.38 (7), p.1341-1346

2023

Volltextzugriff (PDF)

Association Between Change in Body Mass Index, Unified Parkinson's Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease: Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term Study 1

JAMA neurology, 2016-03, Vol.73 (3), p.321

2016

Volltextzugriff (PDF)

Symptomatic treatment in the fragile X-associated tremor/ataxia syndrome

Movement disorders, 2006-10, Vol.21 (10), p.1741-1744

2006

Volltextzugriff (PDF)

An Atmospheric Pressure Chemical Ionization MS/MS Assay Using Online Extraction for the Analysis of 11 Cannabinoids and Metabolites in Human Plasma and Urine

Therapeutic drug monitoring, 2017-10, Vol.39 (5), p.556-564

2017

Volltextzugriff (PDF)

Neuropathy as a presenting feature in fragile X-associated tremor/ataxia syndrome

American journal of medical genetics. Part A, 2007-10, Vol.143A (19), p.2256-2260

2007

Volltextzugriff (PDF)

Fibromyalgia in fragile X mental retardation 1 gene premutation carriers

Rheumatology (Oxford, England), 2011-12, Vol.50 (12), p.2233-2236

2011

Volltextzugriff (PDF)

Eye Movements in Fragile X-Associated Tremor/Ataxia Syndrome

Journal of neuro-ophthalmology, 2021-12, Vol.41 (4), p.e661-e664

2021

Volltextzugriff (PDF)

Identifying susceptibility genes for primary ovarian insufficiency on the high-risk genetic background of a fragile X premutation

Fertility and sterility, 2021-09, Vol.116 (3), p.843-854

2021

Volltextzugriff (PDF)

Memantine for fragile X-associated tremor/ataxia syndrome: a randomized, double-blind, placebo-controlled trial

The journal of clinical psychiatry, 2014-03, Vol.75 (3), p.264-271

2014

Volltextzugriff (PDF)

Higher Risk, Higher Reward? Self‐Reported Effects of Real‐World Cannabis Use in Parkinson's Disease

Movement disorders clinical practice (Hoboken, N.J.), 2022-04, Vol.9 (3), p.340-350

2022

Volltextzugriff (PDF)

Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population

JAMA : the journal of the American Medical Association, 2004-01, Vol.291 (4), p.460

2004

Volltextzugriff (PDF)

Parkinsonism in fragile X-associated tremor/ataxia syndrome (FXTAS): Revisited

Parkinsonism & related disorders, 2014-04, Vol.20 (4), p.456-459

2014

Volltextzugriff (PDF)

1 – 25 von 98

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(87)
Mit Volltextzugriff
(76)

Publikationsform

Sprache

Englisch
(98)

Erscheinungsjahr

n.n

Thema

Science & Technology
(69)
Life Sciences & Biomedicine
(68)
Humans
(61)
Male
(48)
Middle Aged
(45)
Neurosciences & Neurology
(42)
Aged
(40)
Clinical Neurology
(39)
Female
(38)
Biological And Medical Sciences
(30)
Medical Sciences
(30)
Neurology
(27)
Fragile X Syndrome - Genetics
(22)
Fragile X Mental Retardation Protein - Genetics
(21)
Ataxia
(20)
Parkinson's Disease
(18)
Tremor - Genetics
(17)
Adult
(16)
Medical Genetics
(16)
Ataxia - Genetics
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Fragile X-Associated Tremor/Ataxia Syndrome: Clinical Phenotype, Diagnosis, and Treatment

AAV2- GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial

Fragile-X syndrome and fragile X-associated tremor/ataxia syndrome: two faces of FMR1

Safety and Tolerability of Cannabidiol in Parkinson Disease: An Open Label, Dose-Escalation Study

A Review of the Current Evidence Connecting Seborrheic Dermatitis and Parkinson's Disease and the Potential Role of Oral Cannabinoids

Fragile X-associated tremor/ataxia syndrome: Clinical features, genetics, and testing guidelines

Acute akathisia following initiation of opicapone: A case report

Fragile X-associated tremor ataxia syndrome rating scale: Revision and content validity using a mixed method approach

Long-term follow-up of a randomized AAV2- GAD gene therapy trial for Parkinson's disease

Clinical Phenotype of Adult Fragile X Gray Zone Allele Carriers: a Case Series

Reply to: Cognitive Safety of Cannabis Products in Parkinson's Disease: Need for Solid Scientific Evidence to Guide Clinicians and Patients Currently on Shaky Grounds

Oral Cannabidiol for Seborrheic Dermatitis in Patients With Parkinson Disease: Randomized Clinical Trial

Progression of tremor and ataxia in male carriers of the FMR1 premutation

Cognitive Safety Data from a Randomized, Double‐Blind, Parallel‐Group, Placebo‐Controlled Phase IIb Study of the Effects of a Cannabidiol and Δ9‐Tetrahydrocannabinol Drug on Parkinson's Disease‐Related Motor Symptoms

Association Between Change in Body Mass Index, Unified Parkinson's Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease: Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term Study 1

Symptomatic treatment in the fragile X-associated tremor/ataxia syndrome

An Atmospheric Pressure Chemical Ionization MS/MS Assay Using Online Extraction for the Analysis of 11 Cannabinoids and Metabolites in Human Plasma and Urine

Neuropathy as a presenting feature in fragile X-associated tremor/ataxia syndrome

Fibromyalgia in fragile X mental retardation 1 gene premutation carriers

Eye Movements in Fragile X-Associated Tremor/Ataxia Syndrome

Identifying susceptibility genes for primary ovarian insufficiency on the high-risk genetic background of a fragile X premutation

Memantine for fragile X-associated tremor/ataxia syndrome: a randomized, double-blind, placebo-controlled trial

Higher Risk, Higher Reward? Self‐Reported Effects of Real‐World Cannabis Use in Parkinson's Disease

Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population

Parkinsonism in fragile X-associated tremor/ataxia syndrome (FXTAS): Revisited

Suchergebnisse filtern